CONCENTRIX CORP's ticker is CNXC and the CUSIP is 20602D101. A total of 357 filers reported holding CONCENTRIX CORP in Q1 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $214,961 | +15.3% | 3,397 | +20.6% | 0.00% | – |
| Q1 2024 | $186,475 | -40.0% | 2,816 | -11.0% | 0.00% | – |
| Q4 2023 | $310,835 | +16.9% | 3,165 | -4.6% | 0.00% | – |
| Q3 2023 | $265,804 | +5.5% | 3,318 | +6.4% | 0.00% | – |
| Q2 2023 | $251,860 | -23.5% | 3,119 | +15.2% | 0.00% | – |
| Q1 2023 | $329,158 | -53.7% | 2,708 | -49.3% | 0.00% | -100.0% |
| Q4 2022 | $710,542 | +211.6% | 5,336 | +161.3% | 0.00% | – |
| Q3 2022 | $228,000 | -10.2% | 2,042 | +9.0% | 0.00% | – |
| Q2 2022 | $254,000 | -28.2% | 1,873 | -11.9% | 0.00% | – |
| Q1 2022 | $354,000 | -52.4% | 2,126 | -49.0% | 0.00% | -100.0% |
| Q4 2021 | $744,000 | -20.4% | 4,168 | -21.1% | 0.00% | 0.0% |
| Q3 2021 | $935,000 | +11.2% | 5,281 | +0.9% | 0.00% | 0.0% |
| Q2 2021 | $841,000 | +1.3% | 5,234 | -5.7% | 0.00% | 0.0% |
| Q1 2021 | $830,000 | +257.8% | 5,553 | +137.3% | 0.00% | – |
| Q4 2020 | $232,000 | – | 2,340 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Groupe Bruxelles Lambert | 8,773,667 | $555,197,648 | 100.00% |
| Impactive Capital LP | 3,846,370 | $243,398,294 | 9.46% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 623,542 | $39,457,738 | 1.80% |
| LYRICAL ASSET MANAGEMENT LP | 1,271,250 | $80,444,700 | 1.29% |
| Copeland Capital Management, LLC | 985,722 | $62,376,533 | 1.17% |
| Nierenberg Investment Management Company, Inc. | 27,910 | $1,766,145 | 0.99% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 564,732 | $35,736,207 | 0.97% |
| VALLEY WEALTH MANAGERS, INC. | 168,482 | $10,661,541 | 0.85% |
| Bragg Financial Advisors, Inc | 202,698 | $12,826,730 | 0.57% |
| CLARK ESTATES INC/NY | 44,250 | $2,800,140 | 0.53% |